Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
IREB2
is a gene that produces
iron regulatory protein 2
(
IRP2
), which is critical to intracellular iron homeostasis and which relates to the rate of cellular proliferation.
IREB2
lies in a lung cancer susceptibility locus. The aims were to assess 1) the relationship between iron loading, cell proliferation and
IRP2
expression in lung cancer; 2) the potential of iron related pathways as therapeutic targets; and 3) the relevance of
IRP2
in operated lung cancer patients.Cells of two nonsmall cell cancer (NSCLC) lines and primary bronchial epithelial cells (PBECs) were cultured with and without iron; and proliferation, apoptosis and migration were assessed. Reverse
transcriptase
PCR and Western blot were used to assess expression of iron homeostasis genes/proteins. Iron chelation and knockdown of
IREB2
were used
in vitro
to explore therapeutics. A cohort of operated NSCLC patients was studied for markers of systemic iron status, tumour
IRP2
staining and survival.Iron loading caused cell proliferation in cancer cell lines, which were less able to regulate
IREB2
expression than PBECs. Iron chelation resulted in a return of proliferation rates to baseline levels; knockdown of
IREB2
had a similar effect.
IRP2
-positive tumours were larger (p=0.045) and higher percentage staining related to poorer survival (p=0.079).Loss of iron regulation represents a poor prognostic marker in lung cancer.
...
PMID:IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer. 2840 45